Agenus Reports Fourth Quarter And Full Year 2014 Financial Results

Agenus Inc. (NASDAQ:AGEN), an immunology company developing novel therapeutic approaches based on checkpoint modulators (CPMs), heat shock protein-based vaccines, and immune adjuvants, today announced its financial results and business highlights for the fourth quarter and year ended December 31, 2014.

Help employers find you! Check out all the jobs and post your resume.

Back to news